Sfoglia per Rivista
P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia
1990-01-01 Carulli, Giovanni; Petrini, Mario; Marini, A; Vaglini, Francesca; Caracciolo, F; Grassi, B.
P-glycoprotein expression in multiple myeloma
1990-01-01 Carulli, Giovanni; Petrini, Mario; Marini, A; Ambrogi, F; Ucci, G; Riccardi, A; Luoni, R; Grassi, B.
Pattern dei linfociti B e produzione in vitro delle immunoglobuline: possibili markers immunologici predittivi della THI?
2006-01-01 Moschese, V; Graziani, S; Avanzini, Ma; Carsetti, R; Di Cesare, S; Marconi, M; La Rocca, M; Chini, L; Soresina, Ar; Bossi, G; Trizzino, A; Martino, S; Cardinale, F; Pignata, C; Consolini, Rita
PDGFRB sustains the "Withdrawal Syndrome" after Imatinib discontinuation
2015-01-01 Galimberti, Sara; Fontanelli, G.; Barsotti, S.; Ricci, F; Guerrini, F; Ciabatti, E.; Grassi, S.; Barate, C.
PERITRANSPLANT SITAGLIPTIN MODIFIES SERUM SDF-1ALPHA LEVELS IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
2008-01-01 Focosi, Daniele; Mattii, Letizia; Metelli, Mr; Maggi, Fabrizio; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Petrini, Mario
Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy.
1999-01-01 Carulli, Giovanni; Papineschi, Federico; Benedetti, E; Vanacore, R; Azzara', Antonio; Petrini, Mario
Plasma cell granuloma of the lung following chemotherapy for lymphocytic lymphoma.
1985-01-01 Carulli, Giovanni; Pingitore, R; Marini, A; Grassi, B.
PLATELET-DERIVED GROWTH FACTOR ß RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
2009-01-01 Galimberti, Sara; Ferreri, M. I.; Simi, P; Baratè, C; Azzarà, A; Carulli, Giovanni; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, F; Petrini, Mario
Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance.
1991-01-01 Papineschi, Federico; Carulli, Giovanni; Petrini, Mario
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi
2016-01-01 Luminari, Stefano; Galimberti, Sara; Versari, Annibale; Biasoli, Irene; Anastasia, Antonella; Rusconi, Chiara; Ferrari, Angela; Petrini, Mario; Manni, Martina; Federico, Massimo
PRECISION OF MULTI-ECHO CMR FOR MYOCARDIAL IRON OVERLOAD EVALUATION IS DEPENDENT FROM MR SEQUENCE DESIGN RID A-6953-2008
2010-01-01 Pepe, A; Positano, V; Meloni, A; Dell'Amico, Mc; Menichetti, L; De Marchi, D; Favilli, B; Rizzello, Mc; Spasiano, A; Gagliardotto, F; Landini, Luigi; Lombardi, M.
Predictive role of WT1 and RPS14 expression in patients affected by myelodysplastic syndromes receiving azacitidine
2013-01-01 Galimberti, Sara; Rocco, M.; Mignone, T.; Grassi, Susanna; Ciabatti, E.; Azzara', Antonio; Petrini, Mario
PS-341 (BORTEZOMIB) INHIBITS BOTH PROLIFERATION OF MEGAKARYOBLASTIC CELLS IN VITRO AND MK COLONIES PRODUCTION IN PATIENTS AFFECTED BY IDIOPATHIC MYELOFIBROSIS
2007-01-01 Galimberti, Sara; Canestraro, M; Ciancia, E; 1 Pacini, S; Trombi, L; Azzarà, A; Carulli, Giovanni; Guerrini, F; Ciabatti, E; Petrini, Mario
PS-341 (Bortezomid) inhibits both proliferation of megakaryoblastic cells in vitro and MK colonies production in patients affected by idiopathic myelofibrosis
2007-01-01 Galimberti, Sara; Canestraro, M; Ciancia, E; Pacini, S; Trombi, L; Azzara', Antonio; Carulli, Giovanni; Guerrini, F; Ciabatti, E; Petrini, Mario
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT.
2013-01-01 Galimberti, Sara; M., Rocco; T., Mingrone; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Mr, Metelli; G., Cervetti; N., Cecconi; F., Ghio; R., Fazzi; Azzara', Antonio; Petrini, Mario
Renal carcinoma in two patients with poor prognosis NHL treated with high-dose chemotherapy and peripheral stem cell autotransplantation
1999-01-01 Caracciolo, F.; Papineschi, Federico; Benedetti, E.; Capochiani, E.; Cecconi, N.; Carulli, Giovanni; Azzara', Antonio; Rosaia, B.; Fazzi, R.; Tonelli, F.; Cernetti, G.; Petrini, Mario
RESPONSE TO DASATINIB IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH D816V KIT MUTATION: 9 ITALIAN CASES
2009-01-01 Rondoni, M; Paolini, S; Colarossi, S; Fabbri, A; Pregno, P; Piccaluga, Pp; Galimberti, Sara; Baratè, C; Papayannidis, C; De Fina, M; Soverini, S; Lauria, F; Baccarani, M; Martinelli, G.
Results of implementation of the AIEOP recommendations for agammaglobulinemia X recessiva (XLA). Natural history and quality of life for 139 patients with XLA.
2010-01-01 Soresina, A; Rondelli, R; Pulcini, S; Quinti, I; Azzan, C; Pietrogrande, Mc; Martino, S; De, Mattia; D, Martire; B, Rossi; P, Moschese; V, Cardinale; F, Pignata; C, Cazzola; Ga, Duse; M, ; Consolini, Rita
RET: “RETE EMATOLOGICA TOSCANA”. A REPRESENTATIVE NETWORK “PATIENT CEN- TRICITY”: A REAL-LIFE OF CHRONIC MYELOID LEUKAEMIA MONITORING AND TREAT- MENT IN TUSCANY
2013-01-01 A., Gozzini; M., Bocchia; Galimberti, Sara; V., Santini; B., Caciagli; E., Fabbri; B., Scappini; C., Biagiotti; F., Pancani; V., Ponziani; A., Sanna; F., Buchi; E., Masala; A., Valencia; A., Bosi
rhG-CSF-induced phenotypic changes of neutrophils from patients undergoing autologous PBSC transtantation
1999-01-01 Carulli, Giovanni; Azzara', Antonio; Papineschi, Federico; Benedetti, E; Caracciolo, F; Cecconi, N; Vanacore, R; Petrini, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia | 1-gen-1990 | Carulli, Giovanni; Petrini, Mario; Marini, A; Vaglini, Francesca; Caracciolo, F; Grassi, B. | |
| P-glycoprotein expression in multiple myeloma | 1-gen-1990 | Carulli, Giovanni; Petrini, Mario; Marini, A; Ambrogi, F; Ucci, G; Riccardi, A; Luoni, R; Grassi, B. | |
| Pattern dei linfociti B e produzione in vitro delle immunoglobuline: possibili markers immunologici predittivi della THI? | 1-gen-2006 | Moschese, V; Graziani, S; Avanzini, Ma; Carsetti, R; Di Cesare, S; Marconi, M; La Rocca, M; Chini, L; Soresina, Ar; Bossi, G; Trizzino, A; Martino, S; Cardinale, F; Pignata, C; Consolini, Rita | |
| PDGFRB sustains the "Withdrawal Syndrome" after Imatinib discontinuation | 1-gen-2015 | Galimberti, Sara; Fontanelli, G.; Barsotti, S.; Ricci, F; Guerrini, F; Ciabatti, E.; Grassi, S.; Barate, C. | |
| PERITRANSPLANT SITAGLIPTIN MODIFIES SERUM SDF-1ALPHA LEVELS IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 1-gen-2008 | Focosi, Daniele; Mattii, Letizia; Metelli, Mr; Maggi, Fabrizio; Galimberti, Sara; Benedetti, E; Papineschi, Federico; Petrini, Mario | |
| Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy. | 1-gen-1999 | Carulli, Giovanni; Papineschi, Federico; Benedetti, E; Vanacore, R; Azzara', Antonio; Petrini, Mario | |
| Plasma cell granuloma of the lung following chemotherapy for lymphocytic lymphoma. | 1-gen-1985 | Carulli, Giovanni; Pingitore, R; Marini, A; Grassi, B. | |
| PLATELET-DERIVED GROWTH FACTOR ß RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE | 1-gen-2009 | Galimberti, Sara; Ferreri, M. I.; Simi, P; Baratè, C; Azzarà, A; Carulli, Giovanni; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, F; Petrini, Mario | |
| Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance. | 1-gen-1991 | Papineschi, Federico; Carulli, Giovanni; Petrini, Mario | |
| Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi | 1-gen-2016 | Luminari, Stefano; Galimberti, Sara; Versari, Annibale; Biasoli, Irene; Anastasia, Antonella; Rusconi, Chiara; Ferrari, Angela; Petrini, Mario; Manni, Martina; Federico, Massimo | |
| PRECISION OF MULTI-ECHO CMR FOR MYOCARDIAL IRON OVERLOAD EVALUATION IS DEPENDENT FROM MR SEQUENCE DESIGN RID A-6953-2008 | 1-gen-2010 | Pepe, A; Positano, V; Meloni, A; Dell'Amico, Mc; Menichetti, L; De Marchi, D; Favilli, B; Rizzello, Mc; Spasiano, A; Gagliardotto, F; Landini, Luigi; Lombardi, M. | |
| Predictive role of WT1 and RPS14 expression in patients affected by myelodysplastic syndromes receiving azacitidine | 1-gen-2013 | Galimberti, Sara; Rocco, M.; Mignone, T.; Grassi, Susanna; Ciabatti, E.; Azzara', Antonio; Petrini, Mario | |
| PS-341 (BORTEZOMIB) INHIBITS BOTH PROLIFERATION OF MEGAKARYOBLASTIC CELLS IN VITRO AND MK COLONIES PRODUCTION IN PATIENTS AFFECTED BY IDIOPATHIC MYELOFIBROSIS | 1-gen-2007 | Galimberti, Sara; Canestraro, M; Ciancia, E; 1 Pacini, S; Trombi, L; Azzarà, A; Carulli, Giovanni; Guerrini, F; Ciabatti, E; Petrini, Mario | |
| PS-341 (Bortezomid) inhibits both proliferation of megakaryoblastic cells in vitro and MK colonies production in patients affected by idiopathic myelofibrosis | 1-gen-2007 | Galimberti, Sara; Canestraro, M; Ciancia, E; Pacini, S; Trombi, L; Azzara', Antonio; Carulli, Giovanni; Guerrini, F; Ciabatti, E; Petrini, Mario | |
| R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. | 1-gen-2013 | Galimberti, Sara; M., Rocco; T., Mingrone; Ciabatti, Elena; Grassi, Susanna; Guerrini, Francesca; Mr, Metelli; G., Cervetti; N., Cecconi; F., Ghio; R., Fazzi; Azzara', Antonio; Petrini, Mario | |
| Renal carcinoma in two patients with poor prognosis NHL treated with high-dose chemotherapy and peripheral stem cell autotransplantation | 1-gen-1999 | Caracciolo, F.; Papineschi, Federico; Benedetti, E.; Capochiani, E.; Cecconi, N.; Carulli, Giovanni; Azzara', Antonio; Rosaia, B.; Fazzi, R.; Tonelli, F.; Cernetti, G.; Petrini, Mario | |
| RESPONSE TO DASATINIB IN PATIENTS WITH SYSTEMIC MASTOCYTOSIS WITH D816V KIT MUTATION: 9 ITALIAN CASES | 1-gen-2009 | Rondoni, M; Paolini, S; Colarossi, S; Fabbri, A; Pregno, P; Piccaluga, Pp; Galimberti, Sara; Baratè, C; Papayannidis, C; De Fina, M; Soverini, S; Lauria, F; Baccarani, M; Martinelli, G. | |
| Results of implementation of the AIEOP recommendations for agammaglobulinemia X recessiva (XLA). Natural history and quality of life for 139 patients with XLA. | 1-gen-2010 | Soresina, A; Rondelli, R; Pulcini, S; Quinti, I; Azzan, C; Pietrogrande, Mc; Martino, S; De, Mattia; D, Martire; B, Rossi; P, Moschese; V, Cardinale; F, Pignata; C, Cazzola; Ga, Duse; M, ; Consolini, Rita | |
| RET: “RETE EMATOLOGICA TOSCANA”. A REPRESENTATIVE NETWORK “PATIENT CEN- TRICITY”: A REAL-LIFE OF CHRONIC MYELOID LEUKAEMIA MONITORING AND TREAT- MENT IN TUSCANY | 1-gen-2013 | A., Gozzini; M., Bocchia; Galimberti, Sara; V., Santini; B., Caciagli; E., Fabbri; B., Scappini; C., Biagiotti; F., Pancani; V., Ponziani; A., Sanna; F., Buchi; E., Masala; A., Valencia; A., Bosi | |
| rhG-CSF-induced phenotypic changes of neutrophils from patients undergoing autologous PBSC transtantation | 1-gen-1999 | Carulli, Giovanni; Azzara', Antonio; Papineschi, Federico; Benedetti, E; Caracciolo, F; Cecconi, N; Vanacore, R; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile